FBRX - Forte Biosciences, Inc.
28.76
-1.520 -5.285%
Share volume: 256,968
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$30.28
-1.52
-0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-14-2024 | 11-14-2024 | 03-28-2025 | 05-15-2025 | 08-14-2025 | 11-14-2025 | |
| Cash flow financing | -8.000 K | -10.000 K | -2.000 K | 51.877 M | -2.322 M | 70.349 M | 1.325 M | |
| Other financing cash flows | -16.000 K | -10.000 K | -8.000 K | -1.000 K | -15.000 K | -1.000 K | 12.000 K | |
| Cash flow | -6.681 M | 0.000 | 0.000 | 5.881 M | 23.612 M | 0.000 | -12.730 M | |
| Net income | -7.420 M | -12.511 M | -8.392 M | -7.155 M | -15.656 M | -11.249 M | -17.682 M | |
| Depreciation | 9.000 K | 10.000 K | 10.000 K | 10.000 K | 13.000 K | 15.000 K | 17.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -6.000 K | 0.000 | 0.000 | -35.987 M | 36.289 M | 0.000 | -55.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 6.000 K | 0.000 | 0.000 | 31.000 K | 61.000 K | 0.000 | 55.000 K | |
| Cash Change | -6.681 M | -5.946 M | -8.135 M | 5.881 M | 23.612 M | 60.288 M | -12.730 M |